1. Home
  2. LTRN vs POM Comparison

LTRN vs POM Comparison

Compare LTRN & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.03

Market Cap

38.7M

Sector

Health Care

ML Signal

HOLD

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.24

Market Cap

38.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
LTRN
POM
Founded
2013
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
38.8M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
LTRN
POM
Price
$3.03
$0.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
55.6K
457.8K
Earning Date
11-12-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$51,210,721.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.13
52 Week Low
$2.55
$0.22
52 Week High
$5.74
$6.43

Technical Indicators

Market Signals
Indicator
LTRN
POM
Relative Strength Index (RSI) 38.24 25.43
Support Level $3.32 $0.22
Resistance Level $3.27 $0.27
Average True Range (ATR) 0.20 0.03
MACD -0.04 0.10
Stochastic Oscillator 7.94 22.04

Price Performance

Historical Comparison
LTRN
POM

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: